B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Futibatinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Futibatinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

erdafitinib
5 shared targets
ly
5 shared targets
pemigatinib
4 shared targets
fisogatinib
4 shared targets
h3b
4 shared targets
pd
5 shared targets
fexagratinib
5 shared targets
fgfr
5 shared targets
lucitanib
4 shared targets
tyrphostin
2 shared targets
Loading evidence profile...

This evidence profile for Futibatinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.